Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 5, 2025

November 5, 2025

Rezolute to Host Virtual Investor Event on Ersodetug Development Program

GlobeNewswire

November 5, 2025

Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

Appili Therapeutics Announces Proposed Non-Brokered Private Placement

GlobeNewswire

November 5, 2025

MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering

GlobeNewswire

November 5, 2025

Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call

GlobeNewswire

November 5, 2025

Anika Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program

GlobeNewswire

November 5, 2025

Skye Bioscience Late-Breaking Oral Abstract at ObesityWeek 2025 to Highlight Improvement in Rebound Weight Gain

GlobeNewswire

November 5, 2025

Pluristyx Executes Key Commercial Clinical Use Licenses for iPSC Portfolio, Enabling Novel Therapies for Regenerative Medicine and Neurological Disease Therapeutics

GlobeNewswire

November 5, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 5, 2025

Secura Bio to Participate in the Jefferies Global Healthcare Conference in London

GlobeNewswire

November 5, 2025

Teva's Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS

GlobeNewswire

November 5, 2025

MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab

GlobeNewswire

November 5, 2025

Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference

GlobeNewswire

November 5, 2025

Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025

GlobeNewswire

November 5, 2025

Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025

GlobeNewswire

November 5, 2025

EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments

GlobeNewswire

November 5, 2025

Apellis Pharmaceuticals to Present at the Stifel 2025 Healthcare Conference

GlobeNewswire

November 5, 2025

TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

GlobeNewswire

November 5, 2025

Larimar Therapeutics Reports Third Quarter 2025 Financial Results

GlobeNewswire